Ivacaftor: Five‐year outcomes in the West of Scotland cystic fibrosis population

INTRODUCTION: Ivacaftor has shown to be effective in patients with cystic fibrosis (CF) with a G551D mutation. OBJECTIVES: This work aims to evaluate ivacaftor's effectiveness and safety in the real world, over 5 years, in the West of Scotland CF population. METHODS: We evaluated ivacaftor'...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐Din, Yasmin, Dryden, Carol, MacGregor, Gordon, Young, David, Coelho, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214567/
https://www.ncbi.nlm.nih.gov/pubmed/36938952
http://dx.doi.org/10.1111/crj.13602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214567/
https://www.ncbi.nlm.nih.gov/pubmed/36938952
http://dx.doi.org/10.1111/crj.13602

Ejemplares similares